Case Reports
doi: 10.1002/mds.20683.
Suppression of myoclonus in SCA2 by piracetam
Affiliations
- PMID: 16149096
- DOI: 10.1002/mds.20683
Item in Clipboard
Case Reports
Suppression of myoclonus in SCA2 by piracetam
Mov Disord.
2006 Jan.
Abstract
We report on a 30-year-old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12-18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations.
Copyright (c) 2005 Movement Disorder Society.
Similar articles
-
Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.Mov Disord. 1996 Nov;11(6):691-700. doi: 10.1002/mds.870110615. Mov Disord. 1996. PMID: 8914096
-
High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.Mov Disord. 2003 Apr;18(4):457-9. doi: 10.1002/mds.10364. Mov Disord. 2003. PMID: 12671958 Clinical Trial.
-
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15.Mov Disord. 2013 Sep;28(10):1465. doi: 10.1002/mds.25433. Epub 2013 Mar 14. Mov Disord. 2013. PMID: 23495097 No abstract available.
-
[Spinocerebellar ataxia type 8(SCA 8)].No To Shinkei. 2001 Jan;53(1):34-40. No To Shinkei. 2001. PMID: 11211728 Review. Japanese. No abstract available.
-
Choreas, hereditary and other ataxias, tics, myoclonus, and other movement disorders.Curr Opin Neurol Neurosurg. 1993 Jun;6(3):358-68. Curr Opin Neurol Neurosurg. 1993. PMID: 8507906 Review.
Cited by
-
Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review.Mov Disord Clin Pract. 2014 Jun 6;1(3):154-160. doi: 10.1002/mdc3.12042. eCollection 2014 Sep. Mov Disord Clin Pract. 2014. PMID: 30363920 Free PMC article. Review.
-
Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.Cerebellum. 2014 Dec;13(6):787-90. doi: 10.1007/s12311-014-0587-y. Cerebellum. 2014. PMID: 25084753 No abstract available.
-
The Multiple Faces of Spinocerebellar Ataxia type 2.Ann Clin Transl Neurol. 2017 Aug 10;4(9):687-695. doi: 10.1002/acn3.437. eCollection 2017 Sep. Ann Clin Transl Neurol. 2017. PMID: 28904990 Free PMC article. Review.
-
Myoclonus-Ataxia Syndromes: A Diagnostic Approach.Mov Disord Clin Pract. 2020 Nov 3;8(1):9-24. doi: 10.1002/mdc3.13106. eCollection 2021 Jan. Mov Disord Clin Pract. 2020. PMID: 33426154 Free PMC article. Review.
-
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.Cell Death Dis. 2024 Jun 14;15(6):415. doi: 10.1038/s41419-024-06812-5. Cell Death Dis. 2024. PMID: 38877004 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
